Positive Procedural Control for Immunophenotyping
CD-Chex™ Plus BC is a positive procedural control for monitoring immunophenotyping by flow cytometry. It provides the most assayed CD markers in the industry on a single control, including those on the HIV panel of markers recommended by the CDC and a normal level of CD34+ cells. CD-Chex Plus BC is manufactured from normal human peripheral blood leukocytes and erythrocytes. Available in two clinically relevant levels of CD4+ cells
CD-Chex Plus BC verifies the accuracy and reproducibility of all the steps involved in the process of immunophenotyping, including:
- Verification of mAb reagents
- Verification of red blood cell lysis
- Validation of instrument performance
- Validation of operator technique
Compatible with Beckman Coulter® flow cytometry systems
CD-Chex Plus BC and CD-Chex Plus BC CD4 Low are available in 3.0ml cap-pierceable plastic vials.
Stability
• 90-day closed-vial stability
• 30-day open-vial stability
Click here to see patents that may be applicable to this product.
| CD-Chex Plus BC |
Catalog Number |
| 1x3.0ml CD-Chex Plus BC |
213373 |
| 2x3.0ml CD-Chex Plus BC |
213374 |
| 5x3.0ml CD-Chex Plus BC |
213378 |
| 1x3.0ml CD-Chex Plus BC CD4 Low |
213371 |
| 2x3.0ml CD-Chex Plus BC CD4 Low |
213372 |
| 5x3.0ml CD-Chex Plus BC CD4 Low |
213377 |
| 4x3.0ml CD-Chex Plus BC CD4 Low, Normal |
213375 |
| 10x3.0ml CD-Chex Plus BC CD4 Low, Normal |
213376 |